Halo Neuroscience CEO talks about its dual approach to the neurostimulation market
Daniel Chao, who previously co-founded NeuroPace, said unlike most startups, the company didn't have a specific product in mind when it launched in 2013.
Halo Neuroscience raises $9M Series A for neurostimulation for athletics, stroke rehab
Lux Capital led the round with participation from Andreessen Horowitz, Jazz Venture Partners, SoftTech Ventures and Xfund.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.